Respiratory dysfunction in Guillain-Barré Syndrome

Neurocritical Care

Volumn 1, Issue 4, 2004, Pages 415-422

  Orlikowski, David ^a   Prigent, Hélène ^a   Sharshar, Tarek ^a   Lofaso, Frédéric ^a   Raphael, Jean Claude ^a  

^a RAYMOND POINCARÉ HOSPITAL   (France)

Author keywords

Guillain Barr Syndrome (GBS); Intravenous immunoglobulin; Maximal expiratory pressure; Maximal inspiratory pressure; Plasma exchange; Vital capacity

Indexed keywords

IMMUNOGLOBULIN; LIVER ENZYME; METHYLPREDNISOLONE; NEUROMUSCULAR BLOCKING AGENT; NEUROMUSCULAR DEPOLARIZING AGENT; SEDATIVE AGENT;

ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; ATELECTASIS; BREATHING MUSCLE; BULBAR PARALYSIS; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CLINICAL TRIAL; CONVALESCENCE; COUGHING; DYSPNEA; ELECTROPHYSIOLOGY; ENDOTRACHEAL INTUBATION; EPIDEMIOLOGICAL DATA; FEVER; FLU LIKE SYNDROME; GASTROINTESTINAL HEMORRHAGE; GUILLAIN BARRE SYNDROME; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERKALEMIA; HYPOTENSION; INTENSIVE CARE UNIT; LABORATORY TEST; LIVER TOXICITY; LUNG COMPLICATION; LUNG PRESSURE; MUSCLE FUNCTION; MUSCLE WEAKNESS; NAUSEA; NEUROMUSCULAR DISEASE; PARALYSIS; PATIENT MONITORING; PHYSIOTHERAPY; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; TRACHEOSTOMY; TREATMENT INDICATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA; VITAL CAPACITY;

GUILLAIN-BARRE SYNDROME; HUMANS; INTENSIVE CARE UNITS; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; RISK FACTORS; TRACHEOSTOMY;

EID: 24644501706     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:1:4:415     Document Type: Review

References (65)

1. Hughes RA, Rees JH. Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis 1997;176 Suppl 2:S92-S98.
2. Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain-Barre syndrome. Arch Neurol 2001;58:893-898.
3. Sharshar T, Chevret S, Bourdain F, Raphael JC. Early predictors of mechanical ventilation in Guillain-Barre syndrome. Crit Care Med 2003;31:278-283.
4. Ropper AH. The Guillain-Barre syndrome. N Engl J Med 1992;326:1130-1136.
5. Ropper AH, Kehne SM. Guillain-Barre syndrome: management of respiratory failure. Neurology 1985;35:1662-1665.
6. Ropper AH. Severe acute Guillain-Barre syndrome. Neurology 1986;36:429-432.
7. Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation. Neurology 2000;54:2311-2315.
8. Raphael JC, Chevret S, Harboun M, Jars-Guincestre MC. Intravenous immune globulins in patients with Guillain-Barre syndrome and contraindications to plasma exchange: 3 days versus 6 days. J Neurol Neurosurg Psychiatry 2001;71:235-238.
9. Raphael JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst Rev 2001;CD001798.
10. Hughes RA, Raphael JC, Swan AV, van Dorn PA. Intravenous immunoglobulin for Guillain-Barre syndrome. Cochrane Database Syst Rev 2001; CD002063.
11. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med 2002;166:518-624.
12. Hahn AF. The challenge of respiratory dysfunction in Guillain-Barre syndrome. Arch Neurol 2001;58:871,872.
13. Chevrolet JC, Deleamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barre syndrome. Am Rev Respir Dis 1991;144:814-818.
14. Wijdicks EF, Borel CO. Respiratory management in acute neurologic illness. Neurology 1998;50:11-20.
15. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27(Suppl):S21-S24.
16. Raphael JC, Masson C, Morice V, et al. [The Landry-Guillain-Barré syndrome. Study of prognostic factors in 223 cases]. Rev Neurol 1986;142:613-624 French.
17. Borel C, Guy J. Ventilatory management in critical neurologic illness. In: Neurologic clinics. (KG J, ed.). WB Saunders, Philadelphia, 1995, 627-644.
18. Moulin DE, Hagen N, Feasby TE, Amireh R, Hahn A. Pain in Guillain-Barre syndrome. Neurology 1997;48:328-331.
19. Hund EF, Borel CO, Cornblath DR, Hanley DF, McKhann GM. Intensive management and treatment of severe Guillain-Barre syndrome. Crit Care Med 1993;21:433-446.
20. Goulon M, Raphael JC, Gajdos P, Patte D. [Bradycardia and oculocardiac reflex in Landry-Guillain-Barre syndrome]. Nouv Presse Med 1978;7:1866 French.
21. Annane D, Baudrie V, Blanc AS, Laude D, Raphael JC, Elghozi JL. Short-term variability of blood pressure and heart rate in Guillain-Barre syndrome without respiratory failure. Clin Sci (Lond) 1999;96:613-621.
22. Pfeiffer G, Netzer J. Spectral analysis of heart rate and blood pressure in Guillain-Barre patients with respiratory failure. J Neurol Sci 1997;150:39-48.
23. Cheng Q, Jiang GX, Press R, et al. Clinical epidemiology of Guillain-Barre syndrome in adults in Sweden 1996-97: a prospective study. Eur J Neurol 2000;7:685-692.
24. Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry 1998;64:74-77.
25. Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988;51:605-612.
26. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Lancet 1997;349:225-230.
27. Plasmapheresis and acute Guillain-Barre syndrome. The Guillain-Barre syndrome Study Group. Neurology 1985;35: 1096-1104.
28. The French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome. Efficiency of plasma exchange in Guillain-Barre syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barre syndrome. Ann Neurol 1987;22:753-761.
29. The French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome. Appropriate number of plasma exchanges in Guillain-Barre syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome. Ann Neurol 1997;41:298-306.
30. van der Meche FG, Schmitz PI. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group. N Engl J Med 1992;326:1123-1129.
31. Guillain-Barre Syndrome Steroid Trial Group. Double-blind trial of intravenous methylprednisolone in Guillain-Barre syndrome. Guillain-Barre Syndrome Steroid Trial Group. Lancet 1993;341:586-590.
32. Plasma exchange in Guillain-Barre syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barre Syndrome. Ann Neurol 1992;32:94-97.
33. Hughes RA, van Der Meche FG. Corticosteroids for treating Guillain-Barre syndrome. Cochrane Database Syst Rev 2000; CD001446.
34. Hughes RA, Hadden RD, Gregson NA, Smith KJ. Pathogenesis of Guillain-Barre syndrome. J Neuroimmunol 1999;100:74-97.
35. Hadden RD, Karch H, Hartung HP, et al. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 2001;56:758-765.
36. McKhann GM, Cornblath DR, Ho T, et al. Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet 1991;338:593-597.
37. Visser LH, van der Meche FG, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barre syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 1996;47:668-673.
38. Visser LH, Schmitz PI, Meulstee J, van Doom PA, van der Meche FG. Prognostic factors of Guillain-Barre syndrome after intravenous immunoglobulin or plasma exchange. Dutch Guillain-Barre Study Group. Neurology 1999;53:598-604.
39. Rantala H, Uhari M, Cherry JD, Shields WD. Risk factors of respiratory failure in children with Guillain-Barre syndrome. Pediatr Neurol 1995;13:289-292.
40. Oomes PG, van der Meche FG, Kleyweg RP. Liver function disturbances in Guillain-Barre syndrome: a prospective longitudinal study in 100 patients. Dutch Guillain-Barre Study Group. Neurology 1996;46:96-100.
41. Ropper AH. Campylobacter diarrhea and Guillain-Barre syndrome. Arch Neurol 1988;45:655,656.
42. Rees JH, Soudain SE, Gregson NA, Hughes RA. Campylobacter jejuni infection and Guillain-Barre syndrome. N Engl J Med 1995;333:1374-1379.
43. Cornblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barre syndrome: description and prognostic value. Ann Neurol 1988;23:354-359.
44. Miller RG, Peterson GW, Daube JR, Albers JW. Prognostic value of electrodiagnosis in Guillain-Barre syndrome. Muscle Nerve 1988;11:769-774.
45. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 1998;44:780-788.
46. Durand MC, Lofaso F, Lefaucheur JP, et al. Electrophysiology to predict mechanical ventilation in Guillain-Barre syndrome. Eur J Neurol 2003;10:39-44.
47. Zifko U, Chen R, Remtulla H, Hahn AF, Koopman W, Bolton CF. Respiratory electrophysiological studies in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1996;60:191-194.
48. Burns TM, Lawn ND, Low PA, Camilleri M, Wijdicks EF. Adynamic ileus in severe Guillain-Barre syndrome. Muscle Nerve 2001;24:963-965.
49. Fromageot C, Lofaso F, Annane D, et al. Supine fall in lung volumes in the assessment of diaphragmatic weakness in neuromuscular disorders. Arch Phys Med Rehabil 2001;82:123-128.
50. Vianello A, Bevilacqua M, Arcaro G, Gallan F, Serra E. Non-invasive ventilatory approach to treatment of acute respiratory failure in neuromuscular disorders. A comparison with endotracheal intubation. Intensive Care Med 2000;26:384-390.
51. Chalela JA. Pearls and pitfalls in the intensive care management of Guillain-Barre syndrome. Semin Neurol 2001;21:399-405.
52. Bert F, Lambert-Zechovsky N. Sinusitis in mechanically ventilated patients and its role in the pathogenesis of nosocomial pneumonia. Eur J Clin Microbiol Infect Dis 1996;15:533-544.
53. Maziak DE, Meade MO, Todd TR. The timing of tracheotomy: a systematic review. Chest 1998;114:605-609.
54. Plummer AL, Gracey DR. Consensus conference on artificial airways in patients receiving mechanical ventilation. Chest 1989;96:178-180.
55. Lawn ND, Wijdicks EF. Tracheostomy in Guillain-Barre syndrome. Muscle Nerve 1999;22:1058-1062.
56. Lawn ND, Wijdicks EF. Post-intubation pulmonary function test in Guillain-Barre syndrome. Muscle Nerve 2000; 23:613-616.
57. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med 1998;338:791-797.
58. Bach JR, Zhitnikov S. The management of neuromuscular ventilatory failure. Semin Pediatr Neurol 1998;5:92-105.
59. Henderson RD, Lawn ND, Fletcher DD, McClelland RL, Wijdicks EF. The morbidity of Guillain-Barre syndrome admitted to the intensive care unit. Neurology 2003;60:17-21.
60. Lawn ND, Wijdicks EF. Fatal Guillain-Barre syndrome. Neurology 1999;52:635-638.
61. Bouget J, Chevret S, Chastang C, Raphael JC. Plasma exchange morbidity in Guillain-Barre syndrome: results from the French prospective, randomized, multicenter study. The French Cooperative Group. Crit Care Med 1993;21:651-658.
62. Ahsan N. Intravenous immunoglobulin-inducednephropathy: a complication of IVIG therapy. J Nephrol 1998;11:157-161.
63. Borel CO, Tilford C, Nichols DG, Hanley DF, Traystman RJ. Diaphragmatic performance during recovery from acute ventilatory failure in Guillain-Barre syndrome and myasthenia gravis. Chest 1991;99:444-451.
64. Multz AS, Aldrich TK, Prezant DJ, Karpel JP, Hendler JM. Maximal inspiratory pressure is not a reliable test of inspiratory muscle strength in mechanically ventilated patients. Am Rev Respir Dis 1990;142:529-532.
65. A prospective study on the incidence and prognosis of Guillain-Barre syndrome in Emilia-Romagna region, Italy (1992-1993). Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. Neurology 1997;48:214-221.